In vitro kinetic properties of the Thr201Met variant of human aromatase gene CYP19A1: Functional responses to substrate and product inhibition and enzyme inhibitors

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 2998-3002

  Payne, Emily J ^a,b   Ingley, E ^c   Dick, I M ^b   Wilson, S G ^a,b   Bond, C S ^d   Prince, R L ^a,b  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; AROMATASE; CHRYSIN; FORMESTANE; LETROZOLE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXON; GENE; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; KINETICS; PRIORITY JOURNAL;

EID: 68549109423     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2309     Document Type: Article

References (20)

1. Maffei L, Rochira V, Zirilli L, Antunez P, Aranda C, Fabre B, Simone ML, Pignatti E, Simpson ER, Houssami S, Clyne CD, Carani C 2007 A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome. Clin Endocrinol (Oxf) 67:218-224
2. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA 2004 Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 96:936-945
3. Zhou DJ, Pompon D, Chen SA 1991 Structure-function studies of human aromatase by site-directed mutagenesis: kinetic properties of mutants Pro-308 →Phe, Tyr-361→Phe, Try-361→Leu, and Phe-406→Arg. Proc Natl Acad Sci 88:410-414
4. Mononen N, SeppäläEH, Duggal P, Autio V, Ikonen T, Ellonen P, Saharinen J, Saarela J, Vihinen M, Tammela TL, Kallioniemi O, Bailey-Wilson JE, Schleutker J 2006 Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors. Cancer Res 66:743-747
5. Ghosh D, Griswold J, Erman M, Pangborn W 2009 Structural basis for androgen specificity and oestrogen synthesis in human aromatase. Nature 457: 219-223
6. Smith DB, Johnson KS 1988 Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40
7. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein, utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
8. Lineweaver H, Burk D 1934 The determination of enzyme dissociation constants. J Am Chem Soc 56:658-666
9. Dixon M 1953 The determination of enzyme inhibitor constants. Biochem J 55:170-171
10. Haehner BD, Gorski JC, Vandenbranden M, Wrighton SA, Janardan SK, Watkins PB, Hall SD 1996 Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 50:52-59
11. Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED 1997 Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther 281:400-411
12. Tang W, Wang RW, Lu AY 2005 Utility of recombinant cytochrome P450 enzymes: a drug metabolism perspective. Curr Drug Metab 6:503-517
13. Lin Y, Lu P, Tang C, Mei Q, Sandig G, Rodrigues AD, Rushmore TH, Shou M 2001 Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. Drug Metab Dispos 29:368-374
14. Nelson DR, Kamataki T, Waxman DJ, Guengerich FP, Estabrook RW, Feyereisen R, Gonzalez FJ, Coon MJ, Gunsalus IC, Gotoh O 1993 The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol 12:1-51
15. Zhou D, Cam LL, Laughton CA, Korzekwa KR, Chen S 1994 Mutagenesis study at a postulated hydrophobic region near the active site of aromatase cytochrome P450. J Biol Chem 269:19501-19508
16. Graham-Lorence S, Amarneh B, White RE, Peterson JA, Simpson ER 1995 A three-dimensional model of aromatase cytochrome P450. Protein Sci 4:1065-1080
17. Kao YC, Cam LL, Laughton CA, Zhou D, Chen S 1996 Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study. Cancer Res 56:3451-3460
18. Bhatnagar AS 2007 The discovery and mechanism of action of letrozole. Breast Cancer Res Treat [Erratum (2008) 112:385] 105 Suppl 1:7-17
19. Ibrahim AR, Abul-Hajj YJ 1990 Aromatase inhibition by flavonoids. J Steroid Biochem Mol Biol 37:257-260
20. Brodie AM, Garrett WM, Hendrickson JR, Tsai-Morris CH, Marcotte PA, Robinson CH 1981 Inactivation of aromatase in vitro by 4-hydroxy-4- androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo. Steroids 38:693-702